bevacizumab-bvzr 100 MG in 4 ML Injection
- RxCUI
- 2268039
- RxNorm name
- bevacizumab-bvzr 100 MG in 4 ML Injection
- Display name
- bevacizumab-bvzr 100 MG in 4 ML Injection
- Full name
- bevacizumab-bvzr 100 MG in 4 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761099 | Zirabev | bevacizumab-bvzr | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zirabev | BEVACIZUMAB-BVZR | Pfizer Laboratories Div Pfizer Inc | aa27acbd-d117-4350-aeee-17bc2e2c0ca4 | 2026-07-21 | Warnings, Adverse reactions | 2268039 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| aa27acbd-d117-4350-aeee-17bc2e2c0ca4 | bevacizumab-bvzr 100 MG in 4 ML Injection [PSN] · 4 ML bevacizumab-bvzr 25 MG/ML Injection [SCD] · bevacizumab-bvzr 100 MG per 4 ML Injection [SY] · bevacizumab-bvzr 25 MG/ML per 4 ML Injection [SY] | 4 | 12 | These highlights do not include all the information needed to use ZIRABEV safely and effectively. See full prescribing information for ZIRABEV. ZIRABEV™ (bevacizumab-bvzr) injection, for intravenous use Initial U.S. Approval: 2019 ZIRABEV (bevacizumab-bvzr) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betw | 20250805 |